How and Where to Buy Enhertu in India

Enhertu contains fam-trastuzumab deruxtecan-nxki, which is typically a HER2-directed antibody and topoisomerase inhibitor conjugate. This medicinal product (fam-trastuzumab deruxtecan-nxki) is an antibody-drug conjugate composed of (3) three different components: a humanized anti-HER2 IgG1 monoclonal antibody, covalently associated with, a topoisomerase inhibitor, via tetrapeptide-based cleavable linker. The medicine Enhertu injection is approved by the FDA for […]

Enhertu Warning and Precautions

Enhertu (Trastuzumab) is an FDA-approved medicine which is recommended for treating patients with unresectable or metastatic HER2-positive breast cancer, unresectable or metastatic HER2-low (IHC 1+ or IHC 2+/ISH-) breast cancer, unresectable or metastatic non-small cell lung cancer (NSCLC) and locally advanced or metastatic HER2-positive gastric/ gastroesophageal junction (GEJ) adenocarcinoma. The FDA approved this drug in 2019.  Warnings […]